<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD00400000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>Q07812</UniProt_ID>
  <Seq_Length>192</Seq_Length>
  <Molecule_Weight>21184</Molecule_Weight>
  <KEGG_ID>hsa:581</KEGG_ID>
  <Orthology_ID>K02159</Orthology_ID>
  <EBI_ID>EBI-516580</EBI_ID>
  <Function_Summary>Accelerates programmed cell death by binding to, and antagonizing the apoptosis repressor BCL2 or its adenovirus homolog E1B 19k protein. Under stress conditions, undergoes a conformation change that causes translocation to the mitochondrion membrane, leading to the release of cytochrome c that then triggers apoptosis. Promotes activation of CASP3, and thereby apoptosis.</Function_Summary>
  <Pfam_ID>PF00452:Bcl-2</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>0</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>Bcl2-L-4</Alias>
      <Alias>Bcl-2-like protein 4</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with an identical protein to form a homodimer.</Detail>
      <Keyword>Protein homodimerization activity</Keyword>
      <Ontology_ID>GO:0042803</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with the BH3 domain of a protein of the Bcl-2 family. The BH3 domain is a potent death domain and has an important role in protein-protein interactions and in cell death.</Detail>
      <Keyword>BH3 domain binding</Keyword>
      <Ontology_ID>GO:0051434</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.</Detail>
      <Keyword>Protein heterodimerization activity</Keyword>
      <Ontology_ID>GO:0046982</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of energy-independent facilitated diffusion, mediated by passage of a solute through a transmembrane aqueous pore or channel. Stereospecificity is not exhibited but this transport may be specific for a particular molecular species or class of molecules.</Detail>
      <Keyword>Channel activity</Keyword>
      <Ontology_ID>GO:0015267</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a lipid.</Detail>
      <Keyword>Lipid binding</Keyword>
      <Ontology_ID>GO:0008289</Ontology_ID>
    </Funtion>
  </Function_List>
  <Mutation_List>
    <Muntion>
      <Position>108</Position>
      <Original>Gly</Original>
      <Variation>Val</Variation>
    </Muntion>
    <Muntion>
      <Position>67</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
    <Muntion>
      <Position>11</Position>
      <Original>Gly</Original>
      <Variation>Glu</Variation>
    </Muntion>
    <Muntion>
      <Position>39</Position>
      <Original>Gly</Original>
      <Variation>Arg</Variation>
    </Muntion>
  </Mutation_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of protein homodimerization, interacting selectively with an identical protein to form a homodimer.</Detail>
      <Keyword>Regulation of protein homodimerization activity</Keyword>
      <Ontology_ID>GO:0043496</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The breakdown of the nucleus into small membrane-bounded compartments, or blebs, each of which contain compacted DNA.</Detail>
      <Keyword>Nuclear fragmentation involved in apoptotic nuclear change</Keyword>
      <Ontology_ID>GO:0030264</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The conversion of proteins that induce or sustain apoptosis to an active form.</Detail>
      <Keyword>Activation of pro-apoptotic gene products</Keyword>
      <Ontology_ID>GO:0008633</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process of creating protein oligomers, compounds composed of a small number, usually between three and ten, of identical component monomers. Oligomers may be formed by the polymerization of a number of monomers or the depolymerization of a large protein polymer.</Detail>
      <Keyword>Protein homooligomerization</Keyword>
      <Ontology_ID>GO:0051260</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Apoptosis that occurs in response to a stimulus indicating endoplasmic reticulum (ER) stress. ER stress usually results from the accumulation of unfolded or misfolded proteins in the ER lumen.</Detail>
      <Keyword>Apoptosis in response to endoplasmic reticulum stress</Keyword>
      <Ontology_ID>GO:0070059</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process of apoptosis in B cells.</Detail>
      <Keyword>B cell apoptosis</Keyword>
      <Ontology_ID>GO:0001783</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process of apoptosis in transformed cells, cells that have undergone changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm.</Detail>
      <Keyword>Transformed cell apoptosis</Keyword>
      <Ontology_ID>GO:0006927</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Merging of two or more mitochondria within a cell to form a single compartment.</Detail>
      <Keyword>Mitochondrial fusion</Keyword>
      <Ontology_ID>GO:0008053</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a toxin stimulus.</Detail>
      <Keyword>Response to toxin</Keyword>
      <Ontology_ID>GO:0009636</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The directed movement of ions to establish or maintain an electrochemical gradient across a membrane by means of some agent such as a transporter or pore.</Detail>
      <Keyword>Establishment or maintenance of transmembrane electrochemical gradient</Keyword>
      <Ontology_ID>GO:0010248</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of protein oligomerization.</Detail>
      <Keyword>Positive regulation of protein oligomerization</Keyword>
      <Ontology_ID>GO:0032461</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process in which enzymes, such as aspartate aminotransferase, are enabled to move from the mitochondrial matrix into the cytosol.</Detail>
      <Keyword>Release of matrix enzymes from mitochondria</Keyword>
      <Ontology_ID>GO:0032976</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the establishment or extent of the mitochondrial membrane potential, the electric potential existing across the mitochondrial membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane.</Detail>
      <Keyword>Regulation of mitochondrial membrane potential</Keyword>
      <Ontology_ID>GO:0051881</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of survival gene product expression; survival gene products are those that antagonize the apoptotic program. Regulation can be at the transcriptional, translational, or posttranslational level.</Detail>
      <Keyword>Negative regulation of survival gene product expression</Keyword>
      <Ontology_ID>GO:0008634</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that modulates the frequency, rate or extent of protein heterodimerization, interacting selectively with a nonidentical protein to form a heterodimer.</Detail>
      <Keyword>Regulation of protein heterodimerization activity</Keyword>
      <Ontology_ID>GO:0043497</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Upregulation of the activity of a caspase, any of a group of cysteine proteases involved in apoptosis, mediated by cytochrome c.</Detail>
      <Keyword>Activation of caspase activity by cytochrome c</Keyword>
      <Ontology_ID>GO:0008635</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The change in the morphology of the mitochondria in an apoptotic cell from a highly branched network to a fragmented vesicular form.</Detail>
      <Keyword>Mitochondrial fragmentation involved in apoptosis</Keyword>
      <Ontology_ID>GO:0043653</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The proteolytic degradation of lamins during apoptosis, leading to the irreversible breakdown of the nuclear lamina.</Detail>
      <Keyword>Cleavage of lamin</Keyword>
      <Ontology_ID>GO:0006922</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of protein binding.</Detail>
      <Keyword>Negative regulation of protein binding</Keyword>
      <Ontology_ID>GO:0032091</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that increases the rate, frequency or extent of release of cytochrome c from mitochondria, the process in which cytochrome c is enabled to move from the mitochondrial intermembrane space into the cytosol, which is an early step in apoptosis and leads to caspase activation.</Detail>
      <Keyword>Positive regulation of release of cytochrome c from mitochondria</Keyword>
      <Ontology_ID>GO:0090200</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process induced by extracellular signals that directly activates any of the steps required for cell death by apoptosis.</Detail>
      <Keyword>Induction of apoptosis by extracellular signals</Keyword>
      <Ontology_ID>GO:0008624</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A form of programmed cell death that begins when a cell receives internal or external signals that trigger the activity of proteolytic caspases, proceeds through a series of characteristic stages typically including rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), and plasma membrane blebbing (but maintenance of its integrity until the final stages of the process), and ends with the death of the cell.</Detail>
      <Keyword>Apoptosis</Keyword>
      <Ontology_ID>GO:0006915</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The cleavage of DNA during apoptosis, which usually occurs in two stages: cleavage into fragments of about 50 kbp followed by cleavage between nucleosomes to yield 200 bp fragments.</Detail>
      <Keyword>DNA fragmentation involved in apoptotic nuclear change</Keyword>
      <Ontology_ID>GO:0006309</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that activates or increases the frequency, rate or extent of cell death of neurons by apoptosis.</Detail>
      <Keyword>Positive regulation of neuron apoptosis</Keyword>
      <Ontology_ID>GO:0043525</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>A process which directly activates any of the steps required for programmed cell death in the retina.</Detail>
      <Keyword>Induction of retinal programmed cell death</Keyword>
      <Ontology_ID>GO:0046674</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process induced by intracellular signals that directly activates any of the steps required for cell death by apoptosis.</Detail>
      <Keyword>Induction of apoptosis by intracellular signals</Keyword>
      <Ontology_ID>GO:0008629</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process that results in the movement of cytochrome c from the mitochondrial intermembrane space into the cytosol, which is an early step in apoptosis and leads to caspase activation.</Detail>
      <Keyword>Release of cytochrome c from mitochondria</Keyword>
      <Ontology_ID>GO:0001836</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>1</Position>
      <PTM_Type>N-acetylmethionine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MDGSGEQPRGGGPTSSEQIMKTGALLLQGFIQDRAGRMGGEAPELALDPVPQDASTKKLSECLKRIGDELDSNMELQRMIAAVDTDSPREVFFRVAADMFSDGNFNWGRVVALFYFASKLVLKALCTKVPELIRTIMGWTLDFLRERLLGWIQDQGGWDGLLSYFGTPTWQTVTIFVAGVLTASLTIWKKMG</Protein_Seq>
    <DNA_Seq>ATGGACGGGTCCGGGGAGCAGCCCAGAGGCGGGGGGCCCACCAGCTCTGAGCAGATCATGAAGACAGGGGCCCTTTTGCTTCAGGGTTTCATCCAGGATCGAGCAGGGCGAATGGGGGGGGAGGCACCCGAGCTGGCCCTGGACCCGGTGCCTCAGGATGCGTCCACCAAGAAGCTGAGCGAGTGTCTCAAGCGCATCGGGGACGAACTGGACAGTAACATGGAGCTGCAGAGGATGATTGCCGCCGTGGACACAGACTCCCCCCGAGAGGTCTTTTTCCGAGTGGCAGCTGACATGTTTTCTGACGGCAACTTCAACTGGGGCCGGGTTGTCGCCCTTTTCTACTTTGCCAGCAAACTGGTGCTCAAGGCCCTGTGCACCAAGGTGCCGGAACTGATCAGAACCATCATGGGCTGGACATTGGACTTCCTCCGGGAGCGGCTGTTGGGCTGGATCCAAGACCAGGGTGGTTGGGACGGCCTCCTCTCCTACTTTGGGACGCCCACGTGGCAGACCGTGACCATCTTTGTGGCGGGAGTGCTCACCGCCTCGCTCACCATCTGGAAGAAGATGGGCTGA</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Colon</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Breast</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Brain</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Testis</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Spleen</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Lung</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Ovary</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Lymphoma</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Mitochondria</CellLocal>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasm</CellLocal>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Membrane Associated</CellLocal>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>BAX</Gene_Name>
    <Gene_Alias>BCL2L4</Gene_Alias>
    <Gene_ID>581</Gene_ID>
    <Genbank_ACCN>NM_004324</Genbank_ACCN>
    <Protein_ACCN>NP_004315</Protein_ACCN>
    <HGNC_ID>959</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/581</Gene_URL>
    <UCSC_ID>uc002pll.3</UCSC_ID>
    <EMBL_ID>ENSG00000087088</EMBL_ID>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>Q07817-1</Uniprot_ID>
      <Gene_Name>BCL2L1</Gene_Name>
      <EBI_ID>EBI-287195</EBI_ID>
      <PPI_EBI_URL>EBI-516580,EBI-287195</PPI_EBI_URL>
      <Experiment_Number>11</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q07820</Uniprot_ID>
      <Gene_Name>MCL1</Gene_Name>
      <EBI_ID>EBI-1003422</EBI_ID>
      <PPI_EBI_URL>EBI-516580,EBI-1003422</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q07812</Uniprot_ID>
      <Gene_Name>BAX</Gene_Name>
      <EBI_ID>EBI-516580</EBI_ID>
      <PPI_EBI_URL>EBI-516580,EBI-516580</PPI_EBI_URL>
      <Experiment_Number>15</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P10415</Uniprot_ID>
      <Gene_Name>BCL2</Gene_Name>
      <EBI_ID>EBI-77694</EBI_ID>
      <PPI_EBI_URL>EBI-516580,EBI-77694</PPI_EBI_URL>
      <Experiment_Number>5</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P70444</Uniprot_ID>
      <Gene_Name>Bid</Gene_Name>
      <EBI_ID>EBI-2128640</EBI_ID>
      <PPI_EBI_URL>EBI-516580,EBI-2128640</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P12956</Uniprot_ID>
      <Gene_Name>XRCC6</Gene_Name>
      <EBI_ID>EBI-353208</EBI_ID>
      <PPI_EBI_URL>EBI-516580,EBI-353208</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P24391</Uniprot_ID>
      <Gene_Name>tom-40</Gene_Name>
      <EBI_ID>EBI-1791540</EBI_ID>
      <PPI_EBI_URL>EBI-516580,EBI-1791540</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q9Y371-1</Uniprot_ID>
      <Gene_Name>SH3GLB1</Gene_Name>
      <EBI_ID>EBI-5291808</EBI_ID>
      <PPI_EBI_URL>EBI-516580,EBI-5291808</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
  </PPI_List>
  <Disease_List>
    <Disease>
      <Disease_Name>Esophageal Cancer</Disease_Name>
      <Disease_Detail>Esophageal Cancer</Disease_Detail>
      <Disease_DB>ESP021</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/esophageal_cancer?search=BAX#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Serous Cystadenocarcinoma</Disease_Name>
      <Disease_Detail>Serous Cystadenocarcinoma</Disease_Detail>
      <Disease_DB>SRS001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/serous_cystadenocarcinoma?search=BAX#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Prostate Cancer</Disease_Name>
      <Disease_Detail>Prostate Cancer</Disease_Detail>
      <Disease_DB>PRS040</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/prostate_cancer?search=BAX#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Adenocarcinoma</Disease_Name>
      <Disease_Detail>Adenocarcinoma</Disease_Detail>
      <Disease_DB>ADN016</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/adenocarcinoma?search=BAX#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Mediterranean Spotted Fever</Disease_Name>
      <Disease_Detail>Mediterranean Spotted Fever</Disease_Detail>
      <Disease_DB>MDT001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/mediterranean_spotted_fever?search=BAX#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Maxillary Sinus Squamous Cell Carcinoma</Disease_Name>
      <Disease_Detail>Maxillary Sinus Squamous Cell Carcinoma</Disease_Detail>
      <Disease_DB>MXL004</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/maxillary_sinus_squamous_cell_carcinoma?search=BAX#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Ovary Adenocarcinoma</Disease_Name>
      <Disease_Detail>Ovarian Cancer</Disease_Detail>
      <Disease_DB>OVR059</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/ovary_adenocarcinoma?search=BAX#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Brain Cancer</Disease_Name>
      <Disease_Detail>Brain Cancer</Disease_Detail>
      <Disease_DB>BRN028</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/brain_cancer?search=BAX#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Lung Cancer</Disease_Name>
      <Disease_Detail>Lung Cancer</Disease_Detail>
      <Disease_DB>LNG032</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/lung_cancer?search=BAX#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>T-Cell Acute Lymphoblastic Leukemia, Somatic</Disease_Name>
      <Disease_Detail>Acute Lymphoblastic Leukemia</Disease_Detail>
      <Disease_DB>TCL015</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/t_cell_acute_lymphoblastic_leukemia_somatic?search=BAX#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Periampullary Adenocarcinoma</Disease_Name>
      <Disease_Detail>Periampullary Adenocarcinoma</Disease_Detail>
      <Disease_DB>PRM014</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/periampullary_adenocarcinoma?search=BAX#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Colorectal Cancer, Somatic</Disease_Name>
      <Disease_Detail>Colorectal Cancer</Disease_Detail>
      <Disease_DB>CLR034</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/colorectal_cancer_somatic?search=BAX#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Fuchs' Endothelial Dystrophy</Disease_Name>
      <Disease_Detail>Fuchs' Endothelial Dystrophy</Disease_Detail>
      <Disease_DB>FCH001</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/fuchs_endothelial_dystrophy?search=BAX#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Malignant Teratoma</Disease_Name>
      <Disease_Detail>Malignant Teratoma</Disease_Detail>
      <Disease_DB>MLG081</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/malignant_teratoma?search=BAX#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Colorectal Cancer</Disease_Name>
      <Disease_Detail>Colorectal Cancer</Disease_Detail>
      <Disease_DB>CLR023</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/colorectal_cancer?search=BAX#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Ovarian Serous Cystadenocarcinoma</Disease_Name>
      <Disease_Detail>Ovarian Cancer</Disease_Detail>
      <Disease_DB>OVR012</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/ovarian_serous_cystadenocarcinoma?search=BAX#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Acute Lymphoblastic Leukemia</Disease_Name>
      <Disease_Detail>Acute Lymphoblastic Leukemia</Disease_Detail>
      <Disease_DB>ACT101</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/acute_lymphoblastic_leukemia?search=BAX#related_genes</Disease_URL>
    </Disease>
    <Disease>
      <Disease_Name>Gastrointestinal System Disease</Disease_Name>
      <Disease_Detail>Gastrointestinal System Disease</Disease_Detail>
      <Disease_DB>GST050</Disease_DB>
      <Disease_URL>http://www.malacards.org/card/gastrointestinal_system_disease?search=BAX#related_genes</Disease_URL>
    </Disease>
  </Disease_List>
  <PDB_List>
    <PDB>
      <PDB_Title>SOLUTION STRUCTURE OF A PRO-APOPTOTIC PROTEIN BAX</PDB_Title>
      <PDB_ID>1F16</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1F16</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of Bax: coregulation of dimer formation and intracellular localization.</PubMed_Title>
      <Author>Suzuki M, et al.</Author>
      <Journal>Cell. 2000 Nov 10;103(4):645-54.</Journal>
      <PubMed_ID>11106734</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>BAX Activation is Initiated at a Novel Interaction Site</PDB_Title>
      <PDB_ID>2K7W</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2K7W</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>BAX activation is initiated at a novel interaction site.</PubMed_Title>
      <Author>Gavathiotis E, et al.</Author>
      <Journal>Nature. 2008 Oct 23;455(7216):1076-81.</Journal>
      <PubMed_ID>18948948</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of the anti-Bax monoclonal antibody 6A7 and a Bax peptide.</PDB_Title>
      <PDB_ID>2G5B</PDB_ID>
      <Resolution>2.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2G5B</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Elucidation of some Bax conformational changes through crystallization of an antibody-peptide complex.</PubMed_Title>
      <Author>Peyerl FM, et al.</Author>
      <Journal>Cell Death Differ. 2007 Mar;14(3):447-52.</Journal>
      <PubMed_ID>16946732</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko05016</Pathway_ID>
      <Pathway_Title>Huntington's disease</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Neurodegenerative diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04722</Pathway_ID>
      <Pathway_Title>Neurotrophin signaling pathway</Pathway_Title>
      <Pathway_Class>Organismal Systems</Pathway_Class>
      <Pathway_Subclass>Nervous system</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05020</Pathway_ID>
      <Pathway_Title>Prion diseases</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Neurodegenerative diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04115</Pathway_ID>
      <Pathway_Title>p53 signaling pathway</Pathway_Title>
      <Pathway_Class>Cellular Processes</Pathway_Class>
      <Pathway_Subclass>Cell growth and death</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05200</Pathway_ID>
      <Pathway_Title>Pathways in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05203</Pathway_ID>
      <Pathway_Title>Viral carcinogenesis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05210</Pathway_ID>
      <Pathway_Title>Colorectal cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04071</Pathway_ID>
      <Pathway_Title>Sphingolipid signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05152</Pathway_ID>
      <Pathway_Title>Tuberculosis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05161</Pathway_ID>
      <Pathway_Title>Hepatitis B</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04071</Pathway_ID>
      <Pathway_Title>Sphingolipid signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04210</Pathway_ID>
      <Pathway_Title>Apoptosis</Pathway_Title>
      <Pathway_Class>Cellular Processes</Pathway_Class>
      <Pathway_Subclass>Cell growth and death</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko04932</Pathway_ID>
      <Pathway_Title>Non-alcoholic fatty liver disease (NAFLD)</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Endocrine and metabolic diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05203</Pathway_ID>
      <Pathway_Title>Viral carcinogenesis</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05014</Pathway_ID>
      <Pathway_Title>Amyotrophic lateral sclerosis (ALS)</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Neurodegenerative diseases</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05166</Pathway_ID>
      <Pathway_Title>HTLV-I infection</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Infectious diseases</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <SCOP_Class>Membrane and cell surface proteins</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.g.b.e.b.i.html</SCOP_URL>
    <CATH_Class>Mainly alpha</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/2k7w</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Reference>Zhang Z, et al. J Biol Chem. 2010,285(23):17614-17627.</Site_Reference>
      <Site_Type>Oligomerization</Site_Type>
      <PubMed_ID>20382739</PubMed_ID>
    </AllostericSite>
  </AllostericSite_List>
  <Allosteric_Pathway>
    <Pathway>W107@@R109@@K119, [1: L63@@K64@@R65], [2: R94, D98, S184]</Pathway>
    <Method>Electronegativity Equalization Method (EEM), mutations</Method>
    <Verified__Residue>L63@@K64@@R65, R94</Verified__Residue>
    <PubMed_Title>Ionescu CM, et al. PLoS Comput Biol. 2012;8(6):e1002565.@@George NM, et al. Genes Dev. 2007,21(15):1937-1948.</PubMed_Title>
    <PubMed_ID>22719244@@17671092</PubMed_ID>
    <is__ref__img>No</is__ref__img>
    <is__display>Yes</is__display>
    <in__pathway__browse>Yes</in__pathway__browse>
  </Allosteric_Pathway>
  <Create_Date>2012-05-31</Create_Date>
</Organism_Record>